Solace Therapeutics

company

About

Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$3M
Industries
Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 1997
Number Of Employee
11 - 50
Operating Status
Active

Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies.

The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3M
Solace Therapeutics has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on Aug 9, 2006 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 9, 2006 Series B $3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Solace Therapeutics is funded by 1 investors. Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Series B